MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients.
Lenos K, Goos JA, Vuist IM, den Uil SH, Delis-van Diemen PM, Belt EJ, Stockmann HB, Bril H, de Wit M, Carvalho B, Giblett S, Pritchard CA, Meijer GA, van Kooyk Y, Fijneman RJ, van Vliet SJ.
Lenos K, et al. Among authors: belt ej.
Oncotarget. 2015 Sep 22;6(28):26278-90. doi: 10.18632/oncotarget.4495.
Oncotarget. 2015.
PMID: 26172302
Free PMC article.